Citadel Fine Pharmaceuticals Senior Officers Welfare Association Profile
Key Indicators
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2008
About Citadel Fine Pharmaceuticals Senior Officers Welfare Association
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93090TN1993GAP025676
- Company No.
025676
- Company Classification
Public Limited Guarantee & Association
- Incorporation Date
25 Aug 1993
- Date of AGM
30 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Citadel Fine Pharmaceuticals Senior Officers Welfare Association?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandar Muthuswamy  | Director | 25-Aug-1993 | Current |
| Natarajan Krishnamurthy | Director | 25-Aug-1993 | Current |
| Ganapathi Seetharaman | Director | 25-Aug-1993 | Current |
| Ramanathan Nagarajan | Director | 25-Aug-1993 | Current |
| Narasimhan Rajagopalan | Director | 25-Aug-1993 | Current |
| Srirangan Krishnamurthy | Director | 25-Aug-1993 | Current |
Financial Performance of Citadel Fine Pharmaceuticals Senior Officers Welfare Association.
Enhance accessibility to Citadel Fine Pharmaceuticals Senior Officers Welfare Association's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Citadel Fine Pharmaceuticals Senior Officers Welfare Association?
Unlock access to Citadel Fine Pharmaceuticals Senior Officers Welfare Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Profins Insurance Broking Private LimitedNarasimhan Rajagopalan is a mutual person
Terramax Realty And Constructions Private LimitedNarasimhan Rajagopalan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Citadel Fine Pharmaceuticals Senior Officers Welfare Association?
Unlock and access historical data on people associated with Citadel Fine Pharmaceuticals Senior Officers Welfare Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citadel Fine Pharmaceuticals Senior Officers Welfare Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citadel Fine Pharmaceuticals Senior Officers Welfare Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.